Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Manuela Pigors, Natalie Gross, Iretiolu M. Ogunsulire, Sabrina Patzelt, Silke Szymczak, Ralf J. Ludwig, Katja Bieber, Alexander Scheffold, Enno Schmidt
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Autoimmune bullous diseases: therapeutic update
10.1007/s40265-026-02292-3 · 2026
Pemphigoid diseases
10.1016/s0140-6736(12)61140-4 · 2013
Bullous pemphigoid
10.1038/s41572-025-00595-5 · 2025
Laminin beta4 is a constituent of the cutaneous basement membrane zone and additional autoantigen of anti-p200 pemphigoid
10.1016/j.jaad.2023.11.014 · 2024
Treg cell-based therapies: challenges and perspectives
10.1038/s41577-019-0232-6 · 2020
Antigen-specific therapeutic approaches for autoimmunity
10.1038/s41587-019-0015-4 · 2019
Lesional Th17 cells and regulatory T cells in bullous pemphigoid
10.1111/j.1600-0625.2011.01378.x · 2011
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid
10.1111/jdv.12091 · 2014
Circulating CD4+CD25brightFOXP3+regulatory T-cells are significantly reduced in bullous pemphigoid patients
10.1007/s00403-012-1213-9 · 2012
T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1111/ced.13135 · 2017
Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects
10.1016/j.jaci.2018.03.014 · 2018
Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease
10.1016/j.jaci.2018.04.006 · 2018
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) associated with pemphigoid nodularis: a case report and review of the literature
10.1016/j.jaad.2005.08.047 · 2006
In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases
10.1111/exd.13415 · 2017
Drug discovery for pemphigoid diseases
10.1002/cpph.55 · 2019
B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita
10.4049/jimmunol.1300310 · 2013
Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita
10.1038/jid.2010.248 · 2011
Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice
10.4049/jimmunol.177.5.3461 · 2006
Gene-diet interactions associated with complex trait variation in an advanced intercross outbred mouse line
10.1038/s41467-019-11952-w · 2019
Selective depletion of Foxp3(+) regulatory T cells induces a scurfy-like disease
10.1084/jem.20061852 · 2007
Advantages of Foxp3(+) regulatory T cell depletion using DEREG mice
10.1002/iid3.33 · 2014
Transient depletion of Foxp3(+) regulatory T cells selectively promotes aggressive beta cell autoimmunity in genetically susceptible DEREG mice
10.3389/fimmu.2021.720133 · 2021
Autoimmune blistering diseases in females: a review
10.1016/j.ijwd.2015.01.002 · 2015
Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease
10.1111/exd.14209 · 2020
Understanding sex differences in autoimmune diseases: Immunologic mechanisms
2025
Gender differences in autoimmune disease
10.1016/j.yfrne.2014.04.004 · 2014
Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management
10.1007/s12016-017-8633-4 · 2018
Anti-p200 pemphigoid
10.1093/bjd/ljaf324 · 2026
Regulatory T cells suppress inflammation and blistering in pemphigoid diseases
10.3389/fimmu.2017.01628 · 2017
Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4
10.1111/imm.12983 · 2018
Optimal isolation of functional Foxp3+ induced regulatory T cells using DEREG mice
10.1371/journal.pone.0044760 · 2012
Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice
10.1016/j.jim.2014.03.005 · 2014
Foxp3+ regulatory T-cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen
10.1002/eji.201444480 · 2015
CD25 signaling regulates the function and stability of peripheral Foxp3+ regulatory T cells derived from the spleen and lymph nodes of mice
10.1016/j.molimm.2016.06.007 · 2016
State-of-the-art diagnosis of autoimmune blistering diseases
10.3389/fimmu.2024.1363032 · 2024
The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases
10.1016/j.imbio.2012.07.015 · 2012
Potential of Murine IgG1 and human IgG4 to inhibit the classical complement and Fcgamma receptor activation pathways
10.3389/fimmu.2018.00958 · 2018
IgG Fc-Glycosylation translates MHCII haplotype into autoimmune skin disease
10.1016/j.jid.2020.06.022 · 2021
Autoantibodies to multiple epitopes on the Non-Collagenous-1 domain of type VII collagen induce blisters
10.1038/jid.2015.51 · 2015
Understanding CD4(+) T cells in autoimmune bullous diseases
10.3389/fimmu.2023.1161927 · 2023
Differential control of immune cell homeostasis by Foxp3(+) regulatory T cells in murine peripheral lymph nodes and spleen
10.1556/eujmi-d-14-00022 · doi-reference
Repeated long-term DT application in the DEREG mouse induces a neutralizing Anti-DT antibody response
10.1155/2016/1450398 · doi-reference
Peripheral B cell subsets in autoimmune diseases: clinical implications and effects of B cell-targeted therapies
10.1155/2020/9518137 · doi-reference